Page last updated: 2024-10-31

moclobemide and Hypermyotonia

moclobemide has been researched along with Hypermyotonia in 1 studies

Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.

Research Excerpts

ExcerptRelevanceReference
"We report a case of severe serotonin syndrome after self-poisoning with two antidepressant drugs, paroxetine (a selective inhibitor of serotonin reuptake) and moclobemide (a reversible inhibitor of MAO-A)."3.69[Serotonin syndrome in acute poisoning with antidepressive agents]. ( Cabot, C; Cathala, B; Fabre, M; Robert, P; Senard, JM, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robert, P1
Senard, JM1
Fabre, M1
Cabot, C1
Cathala, B1

Other Studies

1 other study available for moclobemide and Hypermyotonia

ArticleYear
[Serotonin syndrome in acute poisoning with antidepressive agents].
    Annales francaises d'anesthesie et de reanimation, 1996, Volume: 15, Issue:5

    Topics: Adult; Antidepressive Agents; Benzamides; Humans; Male; Moclobemide; Muscle Hypertonia; Paroxetine;

1996